Alzchem Group (ACT.DE) Stock Price

Alzchem Group Price

🇩🇪XETRA·CLOSED
175.80EUR
Market closed
Today +/-
Today %

Alzchem Group (ACT.DE) Stock | ISIN DE000A2YNT30 | WKN A2YNT3. The current Alzchem Group stock price is 175.8 EUR (2026). Revenue is 625.86 M EUR. Net income is 65.83 M EUR. The P/E ratio is 27.17. Market capitalization is 1.79 B EUR. Alzchem Group operates in the Commodities sector.

Alzchem Group stock price

Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Alzchem Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Alzchem Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Alzchem Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Alzchem Group Stock Price History
DateAlzchem Group Price
Access this data via the Eulerpool API
Get Free API Key

Alzchem Group Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 1999
20.8 M EUR
-6.2 M EUR
-3.2 M EUR
Jan 1, 2000
16.3 M EUR
-36.5 M EUR
-51.1 M EUR
Jan 1, 2007
0 EUR
0 EUR
0 EUR
Jan 1, 2008
0 EUR
0 EUR
0 EUR
Jan 1, 2009
0 EUR
0 EUR
0 EUR
Jan 1, 2010
0 EUR
0 EUR
0 EUR
Jan 1, 2011
0 EUR
0 EUR
0 EUR
Jan 1, 2012
0 EUR
0 EUR
0 EUR
Jan 1, 2013
0 EUR
0 EUR
0 EUR
Jan 1, 2014
0 EUR
0 EUR
0 EUR
Jan 1, 2015
327.2 M EUR
32.8 M EUR
15.3 M EUR
Jan 1, 2016
353.9 M EUR
33.9 M EUR
20.4 M EUR
Jan 1, 2017
195.24 M EUR
23.47 M EUR
16.01 M EUR
Jan 1, 2018
179.98 M EUR
10.49 M EUR
6.64 M EUR
Jan 1, 2019
376.1 M EUR
30.3 M EUR
18 M EUR

Alzchem Group Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 10, 2026, 12:36 PM
 
REVENUE (M EUR)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M EUR)
NET INCOME (M EUR)
NET INCOME GROWTH (%)
DIV. (EUR)
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Alzchem Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Alzchem Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Alzchem Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Alzchem Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Alzchem Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Alzchem Group stock margins

The Alzchem Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Alzchem Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Alzchem Group.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 1999
8.65 %
-29.81 %
-15.38 %
Jan 1, 2000
10.43 %
-223.93 %
-313.5 %
Jan 1, 2007
65.09 %
0 %
0 %
Jan 1, 2008
65.09 %
0 %
0 %
Jan 1, 2009
65.09 %
0 %
0 %
Jan 1, 2010
65.09 %
0 %
0 %
Jan 1, 2011
65.09 %
0 %
0 %
Jan 1, 2012
65.09 %
0 %
0 %
Jan 1, 2013
65.09 %
0 %
0 %
Jan 1, 2014
65.09 %
0 %
0 %
Jan 1, 2015
64.52 %
10.02 %
4.68 %
Jan 1, 2016
63.29 %
9.58 %
5.76 %
Jan 1, 2017
60.97 %
12.02 %
8.2 %
Jan 1, 2018
57.82 %
5.83 %
3.69 %
Jan 1, 2019
60.6 %
8.06 %
4.79 %

Alzchem Group Stock Revenue, EBIT, Earnings per Share

The Alzchem Group earnings per share therefore indicates how much revenue Alzchem Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 1999
4.08 EUR
-1.22 EUR
-0.63 EUR
Jan 1, 2000
2.91 EUR
-6.52 EUR
-9.13 EUR
Jan 1, 2007
0 EUR
0 EUR
0 EUR
Jan 1, 2008
0 EUR
0 EUR
0 EUR
Jan 1, 2009
0 EUR
0 EUR
0 EUR
Jan 1, 2010
0 EUR
0 EUR
0 EUR
Jan 1, 2011
0 EUR
0 EUR
0 EUR
Jan 1, 2012
0 EUR
0 EUR
0 EUR
Jan 1, 2013
0 EUR
0 EUR
0 EUR
Jan 1, 2014
0 EUR
0 EUR
0 EUR
Jan 1, 2015
1,636 EUR
164 EUR
76.5 EUR
Jan 1, 2016
35.04 EUR
3.36 EUR
2.02 EUR
Jan 1, 2017
19.19 EUR
2.31 EUR
1.57 EUR
Jan 1, 2018
17.69 EUR
1.03 EUR
0.65 EUR
Jan 1, 2019
36.87 EUR
2.97 EUR
1.76 EUR

Alzchem Group business model & stock analysis

The AlzChem Group AG is a German chemical company headquartered in Trostberg, Bavaria. The company's history dates back to 1868 when chemist Adolph Frank, along with his brother, founded a company for the production of chemical products. Over the following decades, the range and product portfolio were continuously expanded. Today, AlzChem Group AG is one of the leading manufacturers of specialized chemicals and chemical intermediates. The business model of AlzChem Group AG is characterized by a high emphasis on quality and sustainability. The company works with state-of-the-art production facilities and focuses on efficient resource utilization and environmentally friendly production. AlzChem Group AG's customers come from various industries and primarily use the company's products in agriculture, the automotive industry, and the paper and textile industries. In addition to its headquarters in Trostberg, AlzChem Group AG operates additional production sites in Germany, France, and China. Research and development of new products and technologies are important pillars of the business model. For this purpose, AlzChem Group AG also relies on close cooperation with research institutes and universities. AlzChem Group AG is divided into various business segments, each specializing in the production of specialized chemicals and intermediates. One of the most important business segments is agrochemistry, in which AlzChem Group AG produces fertilizers and crop protection agents, for example. The company uses nitrogen compounds that contribute to improved plant growth. Another important business segment is the chemical and paper industry. AlzChem Group AG produces auxiliaries for paper and cardboard production, as well as certain chemicals for the leather and textile industries, among other things. The company is also active in the polymers and plastics industry, producing acrylamides and polyaspartamides, for example. A third business segment of AlzChem Group AG is fine chemistry and the pharmaceutical industry. The company produces special amino acids for medical applications, for example. These are used, for instance, in nutrition and sports medicine. Another pillar of the company is the production of metallurgical specialty products. AlzChem Group AG produces high-purity magnesium products for aluminum production, as well as calcium carbide for the manufacture of welding electrodes, among other things. Overall, AlzChem Group AG offers a wide range of specialized chemicals and intermediates. The company focuses on the highest quality and sustainability in production and research. AlzChem Group AG's customers come from various industries and use the company's products for a wide range of applications. With a strong focus on research and development, AlzChem Group AG meets the challenges of the future and aims for sustainable growth.

Alzchem Group SWOT Analysis

Strengths

  • AlzChem Group AG has a strong product portfolio encompassing a wide range of chemicals, including specialty chemicals and fine chemicals.
  • The company has a well-established customer base and long-term relationships with key clients, contributing to a stable revenue stream.
  • AlzChem Group AG has state-of-the-art production facilities and advanced technology, enabling efficient and high-quality manufacturing processes.

Weaknesses

  • The company heavily relies on a few major customers, posing a risk of significant revenue loss if any of these relationships are disrupted.
  • AlzChem Group AG may face challenges in rapidly adapting to changing market dynamics and customer demands due to its relatively rigid organizational structure.
  • The company's limited brand recognition compared to larger competitors may pose a barrier to expanding market share and attracting new customers.

Opportunities

  • Growing demand for environmentally friendly and sustainable chemicals presents an opportunity for AlzChem Group AG to develop and market innovative green products.
  • Expansion into emerging markets, such as Asia and South America, can provide new avenues for business growth and diversification.
  • Strategic partnerships or acquisitions with complementary companies can help AlzChem Group AG enhance its product offerings and expand into new market segments.

Threats

  • Intense competition from both domestic and international chemical companies poses a threat to AlzChem Group AG's market share and profitability.
  • Fluctuating raw material prices, particularly those of key ingredients, can impact the company's production costs and overall financial performance.
  • Increasing regulations and stricter environmental standards in the chemical industry may require significant investments to comply, potentially affecting AlzChem Group AG's profitability.

Alzchem Group Eulerpool Fair Value

Alzchem Group historical P/E ratio, EBIT multiple, and P/S ratio

Alzchem Group annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Alzchem Group shares outstanding

The number of shares was Alzchem Group in 2025 — This indicates how many shares 10.174 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 1999
5.1 M base_Shares
Jan 1, 2000
5.6 M base_Shares
Jan 1, 2007
5.6 M base_Shares
Jan 1, 2008
5.6 M base_Shares
Jan 1, 2009
5.6 M base_Shares
Jan 1, 2010
5.6 M base_Shares
Jan 1, 2011
5.6 M base_Shares
Jan 1, 2012
100,000 base_Shares
Jan 1, 2013
200,000 base_Shares
Jan 1, 2014
200,000 base_Shares
Jan 1, 2015
200,000 base_Shares
Jan 1, 2016
10.1 M base_Shares
Jan 1, 2017
10.18 M base_Shares
Jan 1, 2018
10.18 M base_Shares
Jan 1, 2019
10.2 M base_Shares

Alzchem Group Dividend History

8 years of dividend payments · 6 consecutive increases

YearAnnual DividendYoY ChangePayments
20251.8EUR↑ 50.0%1×
May 9, 20251.8EUR↑ 50.0%1/1
20241.2EUR↑ 14.3%1×
20231.05EUR↑ 5.0%1×
20221EUR↑ 29.9%1×
20210.77EUR↑ 2.7%1×
20200.75EUR↑ 733.3%1×
20190.09EUR↓ 18.2%1×
20180.11EUR—1×

Alzchem Group dividend history and estimates

In 2025, Alzchem Group paid a dividend amounting to 1.8 EUR. Dividend means that Alzchem Group distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2018
0.11 EUR
0 EUR
Jan 1, 2019
0.09 EUR
0 EUR
Jan 1, 2020
0.75 EUR
0 EUR
Jan 1, 2021
0.77 EUR
0 EUR
Jan 1, 2022
1 EUR
0 EUR
Jan 1, 2023
1.05 EUR
0 EUR
Jan 1, 2024
1.2 EUR
0 EUR
Jan 1, 2025
1.8 EUR
0 EUR
Invalid Date
0 EUR
2.12 EUR
Invalid Date
0 EUR
2.73 EUR

Alzchem Group dividend payout ratio

In 2025, Alzchem Group had a payout ratio of 33.05%. The payout ratio indicates the percentage of the company's profits that Alzchem Group distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 1999
33.57 %
Jan 1, 2000
33.57 %
Jan 1, 2007
33.57 %
Jan 1, 2008
33.57 %
Jan 1, 2009
33.57 %
Jan 1, 2010
33.57 %
Jan 1, 2011
33.57 %
Jan 1, 2012
33.57 %
Jan 1, 2013
33.57 %
Jan 1, 2014
33.57 %
Jan 1, 2015
33.57 %
Jan 1, 2016
33.57 %
Jan 1, 2017
33.57 %
Jan 1, 2018
168.61 %
Jan 1, 2019
50.85 %
Price targets and forecasts for Alzchem Group are not yet available.

Alzchem Group Earnings Estimates

Alzchem Group Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
10/26/20220.35EUR119.06 MEUR2022 Q3
5/6/20210.71EUR104.04 MEUR2021 Q1
3/19/20210.02EUR81.1 MEUR2020 Q4
11/11/20200.32EUR94.9 MEUR2020 Q3
8/11/20200.65EUR99.23 MEUR2020 Q2

EESG©

Eulerpool ESG Scorecard© for the Alzchem Group stock

61/100
69
Environment
99
Social
15
Governance
E

Environment

20
Scope 1 - Direct Emissions102,919
Scope 2 - Indirect emissions from purchased energy170,932
Scope 3 - Indirect emissions within the value chain315,720
Total CO₂ emissions273,851
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees17.9
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Alzchem Group shareholder structure

% Name
12.59862%
Zoellner (Markus)
Zoellner (Markus)
9.89993%
Loew (Peter)
Loew (Peter)
9.20192%
STALUNA TRADE a.s.
STALUNA TRADE a.s.
4.98886%
Vorderwuelbecke (Martin)
Vorderwuelbecke (Martin)
4.97133%
Janus Henderson Investors
Janus Henderson Investors
4.91121%
JPMorgan Asset Management (Asia Pacific) Limited
JPMorgan Asset Management (Asia Pacific) Limited
4.68372%
JPMorgan Asset Management U.K. Limited
JPMorgan Asset Management U.K. Limited
3.00063%
Seibel (Jan Ulli)
Seibel (Jan Ulli)
2.98524%
Lazard Frères Gestion S.A.S.
Lazard Frères Gestion S.A.S.
2.76054%
DWS Investment GmbH
DWS Investment GmbH
...

Alzchem Group Executives and Management Board

KE

Mr. Klaus Englmaier

(64)

Chief Operating Officer, Member of the Management Board

Compensation1.9 M EUR
GW

Dr. Georg Weichselbaumer

(63)

Chief Scientific Officer, Member of the Management Board

Compensation1.77 M EUR
AN

Mr. Andreas Niedermaier

(60)

Chief Executive Officer, Member of the Management Board

Compensation1.59 M EUR
MZ

Mr. Markus Zoellner

(56)

Chairman of the Supervisory Board · since 2017

Compensation42,000 EUR
CS

Dr. Caspar Von Schnurbein

(51)

Deputy Chairman of the Supervisory Board · since 2017

Compensation32,000 EUR

Alzchem Group Supply Chain

Frequently asked questions about Alzchem Group

The business model of AlzChem Group AG revolves around specialty chemicals and pharmaceuticals. AlzChem Group AG is a global supplier of various chemical products used in a wide range of industries such as agriculture, nutrition, and fine chemicals. The company focuses on manufacturing, marketing, and developing innovative chemicals that meet the specific needs of its customers. AlzChem Group AG aims to provide high-quality products that contribute to the growth and success of its clients, while also ensuring environmental sustainability and maintaining high safety standards. With its diverse portfolio and commitment to excellence, AlzChem Group AG stands as a leading player in the specialty chemicals industry.

All fundamentals and in-depth analysis of Alzchem Group

Our stock analysis for Alzchem Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alzchem Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Alzchem Group Stock
Alzchem Group Revenue→
Alzchem Group Stock
Alzchem Group Net Income→
Alzchem Group Stock
Alzchem Group P/E→
Alzchem Group Stock
Alzchem Group P/S→
Alzchem Group Stock
Alzchem Group EBIT→
Alzchem Group Stock
Alzchem Group Dividend→
Alzchem Group Stock
Alzchem Group Directors Dealings→
Alzchem Group Stock
Alzchem Group Stocks→
Alzchem Group Stock
Alzchem Group Market capitalization→
Alzchem Group Stock
Alzchem Group Debt→
Alzchem Group Stock
Alzchem Group Liabilities→
Alzchem Group Stock
Alzchem Group Equity→
Alzchem Group Stock
Alzchem Group AAQS→
Alzchem Group Stock
Alzchem Group Employees→
Alzchem Group Stock
Alzchem Group ROE→
Alzchem Group Stock
Alzchem Group ROA→
Alzchem Group Stock
Alzchem Group ROCE→